https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-initiation-of-enrollment-to-the-phase-2a-clinical-trial-of-per001-intravitreal-implant-in-diabetic-retinopathy-301892514.html?tc=eml_cleartime
Perfuse Therapeutics Announces Initiation of Enrollment to the Phase 2A Clinical Trial of PER001...
/PRNewswire/ -- Perfuse Therapeutics, a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases is pleased...